| Biliary Disease |
1 |
1 |
| Heart Failure (HF) |
0 |
0.86 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.79 |
| Metabolic Syndrome |
0 |
0.78 |
| Cirrhosis |
0 |
0.67 |
| Fatty Liver |
0 |
0.44 |
| Liver Disease |
0 |
0.4 |
| Liver |
0 |
0.39 |
| Hospital |
0 |
0.34 |
| Liver Failure |
0 |
0.33 |
| Renal Failure |
0 |
0.31 |
| Hypertension |
0 |
0.3 |
| Chronic Kidney Disease |
0 |
0.28 |
| Revenue and Practice Management |
0 |
0.28 |
| Renal Disease |
0 |
0.26 |
| Cardiometabolic Risk Factors |
0 |
0.24 |
| Congestive Heart Failure |
0 |
0.24 |
| Heart |
0 |
0.23 |
| Coronary Artery Disease (CAD) |
0 |
0.2 |
| Acute Kidney Injury |
0 |
0.19 |
| Kidney |
0 |
0.17 |
| Nonalcoholic Steatohepatitis |
0 |
0.17 |
| Lipids Management |
0 |
0.11 |
| Metabolism |
0 |
0.11 |
| Obesity |
0 |
0.11 |
| Social Determinants of Health |
0 |
0.11 |
| Diabetes Mellitus |
0 |
0.06 |
| Dyslipidemia |
0 |
0.06 |
| Endoscopy |
0 |
0.06 |
| Genetics |
0 |
0.06 |
| Hepatitis |
0 |
0.06 |
| Hyperlipidemia |
0 |
0.06 |
| Injury |
0 |
0.06 |
| Inpatient Care |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Paracentesis |
0 |
0.06 |
| Preventive Screening |
0 |
0.06 |
| Sleep |
0 |
0.06 |
| Socioeconomics |
0 |
0.06 |
| Genomic Medicine |
0 |
0.05 |
| Sleep Apnea |
0 |
0.05 |
| Sleep Disorders |
0 |
0.05 |
| Wound Management |
0 |
0.05 |